Global Liver Institute (GLI) applauds the reintroduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the U.S. House of Representatives last Friday.
GLI Supports the Bipartisan Reintroduction of the Treat and Reduce Obesity Act
read more
Global Liver Institute
Patient Stories
GLOBAL LIVER INSTITUTE
Patient Stories
Treatment Strategies and Advancements in Testing – Liver Cancer News
Global Liver Institute brings you key updates on emerging treatment strategies and advocacy efforts from global leaders like the World Hepatitis Alliance. In this issue, we offer new resources, a short quiz to see if your liver is healthy, explore promising early detection methods in Liquid Biopsy and Navigating Advanced HCC, and emphasize the importance of routine liver scanning for individuals with type 2 diabetes.
Global Research and Patient Priorities – Pediatric and Rare Liver Diseases News
Kristin Hatcher, Director of GLI’s Pediatric and Rare Liver Disease Program, joined U.S. and global pharmaceutical leaders for a powerful discussion on gaps in drug development and the critical need to include lived patient experience in both rare and common diseases.
Culturally Relevant Tools to Increase Hepatitis B Screening in Asian American Communities
Infection with hepatitis B poses a serious risk to the health of many Americans – especially in certain groups with high risk, including Asian Americans and Asian-American immigrants. Research has found that, to support universal adult screening recommendations, culturally- and linguistically- appropriate educational tools can increase the rate of screening.
Global Liver Institute Leads Efforts in Urging FDA to Recognize Patient-Defined Progress in Drug Development
At the Global Liver Institute, we believe that it all starts with a patient because only they define what progress means to their lives. By elevating their lived experiences, we ensure that science, policy, and care move in the direction that matters most: toward earlier answers, more options, and a better standard of care.
TROA Reintroduced, Veterans Health Advances, Hep C Bill Introduced, and Senate Considers Medicaid Cuts – Liver Health Policy Update
The House passed H.R. 1, the One Big, Beautiful Bill Act, sending the budget reconciliation package to the Senate.
GLI Works With Congress to Protect Veterans’ Health
Global Liver Institute (GLI), in close coordination with congressional staff, has worked tirelessly to ensure that veterans diagnosed with NASH/MASH have no barriers to their care and treatment.
Global Fatty Liver Day 2025: Elevating Liver Health in the Metabolic Health Conversation
On the second Thursday in June, Global Fatty Liver Day (formerly International NASH Day) spotlights one of the most widespread yet under-addressed health threats of our time: fatty liver disease, increasingly referred to as steatotic liver disease (SLD) in clinical settings. Hosted annually by Global Liver Institute (GLI), this public awareness campaign raises awareness of this silent epidemic and its deep roots in global metabolic health challenges.
GLI Supports the Reintroduction of the Treat and Reduce Obesity Act
Global Liver Institute (GLI) applauds the reintroduction of the bipartisan Treat and Reduce Obesity Act, which was recently introduced by Senators Bill Cassidy (R-LA) and Ben Ray Luján (D-NM).
Hep C Elimination Bill – Statement of Support
Global Liver Institute (GLI) proudly supports legislation (S. 1941) introduced by Senators Bill Cassidy (R-LA) and Chris Van Hollen (D-MD) aiming to implement a nationwide elimination program for the hepatitis C virus (HCV) in the United States.
Liver Health Insights, Events, and a Global Challenge – Fatty Liver Disease News
Global Fatty Liver Day is on June 12 – There’s Still Time to Get Involved!
Addressing Liver Cancer Disparities & Advancing Treatment – Liver Cancer News
This edition features a 5-year update on the Financial Toxicity Tumor Board Model, highlighting how multidisciplinary collaboration can reduce financial barriers to care.